Back to company

Solid Therapeutics ApS: Financial statements 2023

CVR: 43007068

Solid Therapeutics ApS (CVR 43007068) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -2,738,806 and a net result of DKK -3,483,115 compared with DKK -796,818 the year before. Equity amounted to DKK -4,239,933. The company had 2 employees in the financial year.

Gross Profit
-2,738,806 kr.
Profit/Loss
-3,483,115 kr.
Equity
-4,239,933 kr.
Total Assets
10,813,082 kr.
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--2.7 mio.-3.5 mio.-4.2 mio.2
2022--398 t.-797 t.-757 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Solid Therapeutics ApS appoints new auditorDec 7, 2023

As of December 7, 2023, LPOG ApS STATSAUTORISEREDE REVISORER has been appointed auditor of Solid Therapeutics ApS.

Solid Therapeutics ApS: The 2022 annual report is outJun 28, 2023

Solid Therapeutics ApS has published its annual report for 2022. Gross profit came to DKK -397,812, and the net result was DKK -796,818.

Anne Mette Hyldgaard Trauelsen joins Solid Therapeutics ApS as adm. dir.Feb 1, 2023

As of February 1, 2023, Anne Mette Hyldgaard Trauelsen is registered as adm. dir. of Solid Therapeutics ApS.

John Sørensen Haurum steps down as director of Solid Therapeutics ApSFeb 1, 2023

As of February 1, 2023, John Sørensen Haurum has stepped down as director of Solid Therapeutics ApS.

Stine Helene Falsig Petersen registered as owner of Solid Therapeutics ApSFeb 1, 2023

As of February 1, 2023, Stine Helene Falsig Petersen is registered as an owner of Solid Therapeutics ApS with an ownership share of 10%.

Anne Mette Hyldgaard Trauelsen registered as owner of Solid Therapeutics ApSFeb 1, 2023

As of February 1, 2023, Anne Mette Hyldgaard Trauelsen is registered as an owner of Solid Therapeutics ApS with an ownership share of 20%.

Registered as owner of Solid Therapeutics ApSFeb 1, 2023

As of February 1, 2023, is registered as an owner of Solid Therapeutics ApS with an ownership share of 10%.

About Solid Therapeutics ApS

Solid Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of John Sørensen Haurum. The company's owners include John Sørensen Haurum, Stine Helene Falsig Petersen and Anne Mette Hyldgaard Trauelsen. In 2025, the company reported a gross profit of DKK -1,687,751 and a net result of DKK -4,355,625 compared with DKK -6,758,207 the year before. Equity amounted to DKK -15,353,766.

Other financial years